FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of aignostics

image description

Bayer and Aignostics to collaborate on next generation precision oncology

"Together with Bayer, we’re excited to transform AI’s immense potential into a reality for healthcare"

18-Mar-2024 - Bayer and Aignostics GmbH announced a strategic collaboration on several artificial intelligence (AI)-powered approaches with applications in precision oncology drug research and development. Aignostics is a spin-off from one of the world’s leading hospitals, Charité-Universitätsmedizin Berlin, ...

artificial intelligence drug development drug research +3
image description

Aignostics Raises €14m Series A to Advance AI-powered Pathology

Spin-off from Charité developing sophisticated AI models to improve understanding, diagnosis and treatment of complex diseases

19-Sep-2022 - Aignostics, a spin-off from Charité – Universitätsmedizin Berlin, developing novel digital pathology solutions with “Explainable AI” for pharmaceutical research and diagnostics, today announced the closing of an oversubscribed €14m Series A financing round. Wellington Partners led the round, ...

artificial intelligence machine learning pathology +1
image description

Spin-off from Charité want to advance AI-powered pathology

Aignostics Raises €5 Million Seed Round

31-Aug-2020 - Aignostics, a spin-off from Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) pioneering computational pathology for pharmaceutical research and diagnostics, has announced the closing of a €5 M seed round funding. Boehringer Ingelheim Venture Fund (BIVF) led the round, ...

artificial intelligence machine learning pathology +1
image description

Precise diagnostics with artificial intelligence

BIH Digital Health Accelerator guides Aignostics GmbH through its spin-off

27-Apr-2020 - The usual way to determine if a suspicious lump is cancerous involves microscopic examination in a pathology laboratory. To ease the workload of pathologists who face a rising number of cancer cases and increasingly finer molecular details and to enable tailored treatments, scientists at the ...

artificial intelligence cancer diagnostics diagnostics +2